Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

L3Harris (LHX) Announces Quarterly Dividend Increase Of 13%

Published 03/02/2020, 09:47 PM
Updated 07/09/2023, 06:31 AM

L3Harris Technologies Inc. (NYSE:LHX) recently announced that its board of directors has declared a cash dividend on its common stock of 85 cents per share, reflecting a 13.3% hike from the prior payout of 75 cents per share.

Post the issuance of the new rate, the annualized dividend will be $3.40 per share. The hiked dividend is payable on Mar 27, 2020, to shareholders of record as of Mar 13. The current dividend yield of the company is 1.69%, higher than the Zacks industry average of 0.91%.

Factors Supporting Dividend Hikes

A stable financial position enables L3Harris Technologies to maximize shareholders’ value through regular dividend payouts and share repurchases. As of Jan 3, 2020, the company’s cash and cash equivalents totaled $824 million compared to $343 million at the end of 2018. Further, in 2019, L3Harris Technologies’ cash inflow from operating activities amounted to $1,655 million, up from $845 million at 2018-end. Notably, the company returned $165 million in dividends to shareholders during the fourth quarter, led by strong operational performance, acceleration of cost synergies and the successful execution of its portfolio shaping strategy.

Going ahead, the company's accelerating revenue growth across its business segments along with margin expansion will most likely improve its operating cash flow. This, in turn, will enable L3Harris Technologies to expand its capital deployment initiatives, including dividend payouts, share repurchases and reinvestments, to grow its businesses. In this line, it is imperative to mention that the company pledges to return more than $3.5 billion through share repurchases and dividends to its shareholders by the end of 2020.

Dividend Hike in the Defense Space

Stocks paying regular dividends are popular among investors for a number of reasons, as they provide income and capital appreciation, decrease overall portfolio risk, and carry tax advantages, among others. The U.S. defense stocks have been rallying significantly in the past couple of years, courtesy of notable defense budget enhancements made by the Trump administration. This, along with growing geopolitical uncertainties, has been fueling growth in this space, which in turn has been bolstering both top and bottom lines of defense stocks. Thus, stable earnings and cash flow enable defense companies to reward shareholders with regular dividend hikes, thereby positioning them in investors’ good books.

Other companies in the same space, who have also raised their dividends in recent times include Lockheed Martin Corporation (NYSE:LMT) and Northrop Grumman Corporation (NYSE:NOC) . In September 2019, the board of directors of Lockheed Martin authorized a fourth quarter dividend of $2.40 per share, reflecting an increase of 20 cents from the prior dividend figure. Northrop Grumman's board of directors approved a 10% rise in its quarterly common stock dividend in June 2019.

Price Performance

L3Harris Technologies’ stock has gained 23.7% in the past year against the industry’s decline of 8.3%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .



Zacks Rank & Another Key Pick

L3Harris Technologies currently carries a Zacks Rank #2 (Buy).

A top-ranked stock in the same space is Leidos Holdings, Inc. (NYSE:LDOS) , carrying a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Leidos Holdings delivered a four-quarter earnings beat of 11.19%, on average. It currently has a solid long-term earnings growth rate of 7.5%.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Northrop Grumman Corporation (NOC): Free Stock Analysis Report

Lockheed Martin Corporation (LMT): Free Stock Analysis Report

Leidos Holdings, Inc. (LDOS): Free Stock Analysis Report

L3Harris Technologies Inc (LHX): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.